We are live on ! Find out more
SUPN icon

Supernus Pharmaceuticals
SUPN

209 hedge funds and large institutions have $604M invested in Supernus Pharmaceuticals in 2015 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 86 increasing their positions, 56 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

109% more first-time investments, than exits

New positions opened: 48 | Existing positions closed: 23

54% more repeat investments, than reductions

Existing positions increased: 86 | Existing positions reduced: 56

13% more funds holding

Funds holding: 185 → 209 (+24)

1% more call options, than puts

Call options by funds: $2.37M | Put options by funds: $2.35M

8% less capital invested

Capital invested by funds: $659M → $604M (-$55.4M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
209
Holders Change
+24
Holders Change %
+12.97%
% of All Funds
5.48%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
48
Increased
86
Reduced
56
Closed
23
Calls
$2.37M
Puts
$2.35M
Net Calls
+$17K
Net Calls Change
-$45K

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$14.1M
2
NPIC
Neumeier Poma Investment Counsel
California
+$13.9M
3
GT
Glenmede Trust
Pennsylvania
+$10.9M
4
RIM
Ranger Investment Management
Texas
+$6.57M
5
KCM
Kornitzer Capital Management
Kansas
+$6.38M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$107M
2
KIA
Kopp Investment Advisors
Minnesota
-$10.2M
3
State Street
State Street
Massachusetts
-$9.97M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.74M
5
BIM
Bogle Investment Management
Massachusetts
-$7.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
CWG
51
C WorldWide Group
Denmark
$3.2M -$804K -52,000 -18%
EI
52
EAM Investors
California
$3.18M +$334K +21,568 +10%
Wellington Management Group
53
Wellington Management Group
Massachusetts
$3.15M +$2.11M +136,249 +138%
PAM
54
Panagora Asset Management
Massachusetts
$3.1M +$515K +33,294 +17%
Principal Financial Group
55
Principal Financial Group
Iowa
$3.05M +$204K +13,199 +6%
GCP
56
GSA Capital Partners
United Kingdom
$2.95M +$80.3K +5,193 +2%
Bessemer Group
57
Bessemer Group
New Jersey
$2.89M +$596K +38,512 +22%
SEI Investments
58
SEI Investments
Pennsylvania
$2.85M +$1.17M +75,673 +55%
Millennium Management
59
Millennium Management
New York
$2.85M +$3.27M +211,659 New
New York State Common Retirement Fund
60
New York State Common Retirement Fund
New York
$2.77M +$113K +7,299 +4%
JP Morgan Chase
61
JP Morgan Chase
New York
$2.53M +$2.91M +188,105 New
ISL
62
Ingalls & Snyder LLC
New York
$2.46M +$219K +14,188 +8%
PCM
63
Portolan Capital Management
Massachusetts
$2.46M +$2.83M +182,789 New
Marshall Wace
64
Marshall Wace
United Kingdom
$2.35M +$2.7M +174,513 New
BGIM
65
Brandywine Global Investment Management
Pennsylvania
$2.25M +$2.45M +158,680 +1,795%
First Trust Advisors
66
First Trust Advisors
Illinois
$2.23M -$480K -31,045 -16%
SIM
67
Spark Investment Management
New York
$2.14M – – –
ASP
68
Adams Street Partners
Illinois
$2.03M +$2.34M +151,117 New
IHM
69
Iguana Healthcare Management
New York
$2.02M +$232K +15,000 +11%
BIM
70
BlackRock Investment Management
Delaware
$2M +$196K +12,670 +9%
BLM
71
Bennett Lawrence Management
New York
$2M +$1.88M +121,570 +444%
AQR Capital Management
72
AQR Capital Management
Connecticut
$1.97M -$1.02M -65,709 -31%
HLA
73
Hamilton Lane Advisors
Pennsylvania
$1.96M +$2.26M +145,901 New
TCIM
74
TIAA CREF Investment Management
New York
$1.87M -$106K -6,856 -5%
Stifel Financial
75
Stifel Financial
Missouri
$1.72M +$222K +14,360 +13%
1 2
3
4 5

SUPN Hedge Fund Activity: Q4 2015 in Review

209 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Supernus Pharmaceuticals (SUPN) for Q4 2015, worth a combined $604M — down 8.4% from $659M a quarter earlier.

Buyers outnumbered sellers: 48 funds opened new SUPN positions and 23 closed out — a net gain of 25 holders — while 86 added to existing stakes and 56 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $14.1M. The largest seller was NEA Management Company, exiting entirely with an estimated $107M sold.

  • 209 institutional investors held Supernus Pharmaceuticals (SUPN) as of Q4 2015, up from 185 in Q3 2015.
  • Funds reported $604M of Supernus Pharmaceuticals stock for Q4 2015, down 8.4% quarter-over-quarter.
  • 48 funds opened new Supernus Pharmaceuticals positions in Q4 2015 and 23 closed out, a net change of +25 holders.
  • The largest Supernus Pharmaceuticals buyer in Q4 2015 was Acadian Asset Management, an estimated $14.1M added.
  • The largest Supernus Pharmaceuticals seller in Q4 2015 was NEA Management Company, an estimated $107M sold.

Based on aggregated 13F filings for Q4 2015.